Angiogenesis patch trial moves forward:
This article was originally published in Clinica
Executive Summary
Advanced Tissue Sciences has begun a pivotal preclinical trial of its tissue-engineered epicardial patch for stimulating new blood vessel growth and improving the function of damaged heart tissue. The trial will assess the safety of the patch, called Anginera, in large animals. A previous study in mice has shown that the patch can improve overall function in damaged heart tissue without adversely effecting normal heart tissue function. Studies in large animals are required by the US FDA before starting human trials, noted the La Jolla, California firm. An efficacy trial in large animals is to begin this summer.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.